Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?

por Pavletic, Steven Z., Schultz, Kirk R.
Publicado 2022

What Is the Role of HSCT in Philadelphia-Chromosome–Positive and Philadelphia-Chromosome–Like ALL in the Tyrosine Kinase Inhibitor Era?

por Vettenranta, Kim, Dobsinska, Veronika, Kertész, Gabriella, Svec, Peter, Buechner, Jochen, Schultz, Kirk R.
Publicado 2022

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transpl...

por Rozmus, Jacob, Bhatt, Sima T., Buxbaum, Nataliya Prokopenko, Cuvelier, Geoffrey D. E., Li, Amanda M., Kitko, Carrie L., Schultz, Kirk R.
Publicado 2022

“Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”

por Cuvelier, Geoff D. E., Li, Amanda, Drissler, Sibyl, Kariminia, Amina, Abdossamadi, Sayeh, Rozmus, Jacob, Chanoine, Jean-Pierre, Ng, Bernard, Mostafavi, Sara, Brinkman, Ryan R., Schultz, Kirk R.
Publicado 2020

Chronic gvhd dictionary—eurograft cost action initiative consensus report

por Zelić Kerep, Ana, Olivieri, Atillio, Schoemans, Helene, Lawitschka, Anita, Halter, Jörg, Pulanic, Drazen, Dickinson, Anne, Greinix, Hildegard T., Pavletic, Steven Z., Schultz, Kirk R., Lee, Stephanie J., Wolff, Daniel
Publicado 2022

New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report

por Dieudé, Mélanie, West, Lori J., Muruve, Daniel A., Gunaratman, Lakshman, Mohanakumar, Thalachallour, Zorn, Emmanuel, Cairo, Christopher W., Freed, Darren H., Schultz, Kirk R., Fairchild, Robert L., Hébert, Marie-Josée
Publicado 2018

Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Childr...

por Cuvelier, Geoff D.E., Kariminia, Amina, Fujii, Hisaki, Aslanian, Soudabeh, Wall, Donna, Goldman, Fred, Grupp, Stephan A., Dunn, Sandra E., Krailo, Mark, Shapiro, Linda H., Gilman, Andrew, Schultz, Kirk R.
Publicado 2010

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease

por Lauener, Madeline P., AzadPour, Shima, Abdossamadi, Sayeh, Parthasarathy, Vaishnavi, Ng, Bernard, Ostroumov, Elena, Cuvelier, Geoffrey D.E., Levings, Megan K., MacDonald, Katherine N., Kariminia, Amina, Schultz, Kirk R.
Publicado 2022

Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force

por Schofield, Hannah-Lise T., Fabrizio, Vanessa A., Braniecki, Suzanne, Pelletier, Wendy, Eissa, Hesham, Murphy, Beverly, Chewning, Joseph, Barton, Karen D., Embry, Leanne M., Levine, John E., Schultz, Kirk R., Page, Kristin M.
Publicado 2022

Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study

por Rozmus, Jacob, Junker, Anne, Thibodeau, Melanie Laffin, Grenier, Danielle, Turvey, Stuart E., Yacoub, Wadieh, Embree, Joanne, Haddad, Elie, Langley, Joanne M., Ramsingh, Rose Marie, Singh, Veeran-Anne, Long, Richard, Schultz, Kirk R.
Publicado 2013

Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies

por Lorentzian, Amanda, Biegel, Jaclyn A, Ostrow, D Gigi, Rolf, Nina, Liu, Chi-Chao, Rassekh, S Rod, Deyell, Rebecca J, Triche, Timothy, Schultz, Kirk R, Rozmus, Jacob, Reid, Gregor S D, Lim, C James, Lange, Philipp F, Maxwell, Christopher A
Publicado 2019

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

por Schoemans, Helene M., Lee, Stephanie J., Ferrara, James L., Wolff, Daniel, Levine, John E., Schultz, Kirk R., Shaw, Bronwen E., Flowers, Mary E., Ruutu, Tapani, Greinix, Hildegard, Holler, Ernst, Basak, Grzegorz, Duarte, Rafael F., Pavletic, Steven Z.
Publicado 2018

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observa...

por McMahon, Kelly R., Rod Rassekh, Shahrad, Schultz, Kirk R., Pinsk, Maury, Blydt-Hansen, Tom, Mammen, Cherry, Tsuyuki, Ross T., Devarajan, Prasad, Cuvelier, Geoff D. E., Mitchell, Lesley G., Baruchel, Sylvain, Palijan, Ana, Carleton, Bruce C., Ross, Colin J. D., Zappitelli, Michael
Publicado 2017

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

por Buxbaum, Nataliya P., Socié, Gerard, Hill, Geoffrey R., MacDonald, Kelli P. A., Tkachev, Victor, Teshima, Takanori, Lee, Stephanie J., Ritz, Jerome, Sarantopoulos, Stefanie, Luznik, Leo, Zeng, Defu, Paczesny, Sophie, Martin, Paul J., Pavletic, Steven Z., Schultz, Kirk R., Blazar, Bruce R.
Publicado 2022

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference

por Maier, Stephanie A., Berg, Tobias, Berrigan, Susan, Bramson, Jonathan, Bredeson, Chris, Cantin, Guy, Daly, Andrew, Davies, Gwynivere A., Elsawy, Mahmoud, Garcia-Horton, Alejandro, Lam, Wilson, Lapworth, Alix, Lepic, Kylie, Melo Garcia, Luciana, Schultz, Kirk R., Vasudevan Nampoothiri, Ram, White, Darrell, Delisle, Jean-Sébastien
Publicado 2022

Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer

por McMahon, Kelly R., Rassekh, Shahrad Rod, Schultz, Kirk R., Blydt-Hansen, Tom, Cuvelier, Geoffrey D. E., Mammen, Cherry, Pinsk, Maury, Carleton, Bruce C., Tsuyuki, Ross T., Ross, Colin J. D., Palijan, Ana, Huynh, Louis, Yordanova, Mariya, Crépeau-Hubert, Frédérik, Wang, Stella, Boyko, Debbie, Zappitelli, Michael
Publicado 2020

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia...

por Tasian, Sarah K., Silverman, Lewis B., Whitlock, James A., Sposto, Richard, Loftus, Joseph P., Schafer, Eric S., Schultz, Kirk R., Hutchinson, Raymond J., Gaynon, Paul S., Orgel, Etan, Bateman, Caroline M., Cooper, Todd M., Laetsch, Theodore W., Sulis, Maria Luisa, Chi, Yueh-Yun, Malvar, Jemily, Wayne, Alan S., Rheingold, Susan R.
Publicado 2022

Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations

por Sembill, Stephanie, Ampatzidou, Maria, Chaudhury, Sonali, Dworzak, Michael, Kalwak, Krzysztof, Karow, Axel, Kiani, Alexander, Krumbholz, Manuela, Luesink, Maaike, Naumann-Bartsch, Nora, De Moerloose, Barbara, Osborn, Michael, Schultz, Kirk R., Sedlacek, Petr, Giona, Fiorina, Zwaan, Christian Michel, Shimada, Hiroyuki, Versluijs, Birgitta, Millot, Frederic, Hijiya, Nobuko, Suttorp, Meinolf, Metzler, Markus
Publicado 2023

A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases

por Novice, Taylor, Kariminia, Amina, Del Bel, Kate L., Lu, Henry, Sharma, Mehul, Lim, Chinten J., Read, Jay, Lugt, Mark Vander, Hannibal, Mark C., O’Dwyer, David, Hosler, Mirie, Scharnitz, Thomas, Rizzo, Jason M, Zacur, Jennifer, Priatel, John, Abdossamadi, Sayeh, Bohm, Alexandra, Junker, Anne, Turvey, Stuart E., Schultz, Kirk R., Rozmus, Jacob
Publicado 2019

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

por Qayed, Muna, Watkins, Benjamin, Gillespie, Scott, Bratrude, Brandi, Betz, Kayla, Choi, Sung W., Davis, Jeffrey, Duncan, Christine, Giller, Roger, Grimley, Michael, Harris, Andrew C., Jacobsohn, David, Lalefar, Nahal, Norkin, Maxim, Farhadfar, Nosha, Pulsipher, Michael A., Shenoy, Shalini, Petrovic, Aleksandra, Schultz, Kirk R., Yanik, Gregory A., Waller, Edmund K., Langston, Amelia, Kean, Leslie S., Horan, John T.
Publicado 2022